Zhiyong Liang

FGFR4 and HER2 co-expression is associated with the proinflammatory tumor microenvironment in HR + breast cancer.

Tumor-Derived LAMB3 Drives Immunosuppressive LRRC15<sup>+</sup> Fibroblast Formation During Pancreatic Ductal Adenocarcinoma Development.

WHO classification of skin tumours: key updates in the fifth edition.

NTRK Fusion Landscape in 195 Positive Cases of 17 Tumors: A Chinese Multicenter Retrospective Study with Optimized Pan-TRK IHC Screening

Scoring Reliability of c-Met Immunohistochemical Assays in Lung Adenocarcinoma

DB-2B, a Novel and Selective STAT3 Inhibitor Inhibits Colorectal Cancer Progression In Vitro and In Vivo

ALKBH5 in Cancer-Associated Fibroblasts Governs an Epitranscriptomic Axis that Drives Pancreatic Cancer Metastasis.

NFE2-driven neutrophil polarization promotes pancreatic cancer liver metastasis progression

WHO Classification of Tumours: evolution of a global resource in the molecular era

<scp>WHO</scp> classification of skin tumours: key updates in the fifth edition

Molecular and clinicopathological characteristics of invasive breast cancers with HER2-ultralow expression

Identification of constitutional MLH1 methylation in MLH1-deficient colorectal cancer

A 16-year-old female with an intrasellar mass.

The clinicopathological and molecular features of primary high-grade neuroendocrine tumour in the breast.

Prevalence of Atypical and Subclonal p53 Immunohistochemistry Expression in Mismatch Repair Deficient and/or POLE-Mutant Endometrial Carcinomas with TP53 Mutation

1182 Tumor Type, Fusion Partner, and IHC Staining Patterns of 145 Solid Tumor Samples with NTRK3 Fusion: A Chinese Multicenter Retrospective Cross-Sectional Study

Chinese guidelines for HER2 testing in breast cancer (2024 edition): summary of key recommendations

Labor-Efficient Pathological Auxiliary Diagnostic Model for Primary and Metastatic Tumor Tissue Detection in Pancreatic Ductal Adenocarcinoma

Establishing optimized staining protocol and cutoff values of pan-TRK immunohistochemistry for detecting NTRK fusions in solid tumors: A Chinese multicenter cross-sectional study.

Pancreatic stellate cells exploit Wnt/β-catenin/TCF7-mediated glutamine metabolism to promote pancreatic cancer cells growth

Identifying Serum Small Extracellular Vesicle MicroRNA as a Noninvasive Diagnostic and Prognostic Biomarker for Ovarian Cancer.

RNA Sequencing Reveals Novel Oncogenic Fusions and Depicts Detailed Fusion Transcripts of FN1-FGFR1 in Phosphaturic Mesenchymal Tumors

C-X-C Motif Chemokine Ligand 9 Correlates with Favorable Prognosis in Triple-Negative Breast Cancer by Promoting Immune Cell Infiltration.

LBA36 Efficacy and safety of senaparib as maintenance treatment in patients with newly diagnosed advanced ovarian cancer (FLAMES study): A randomized, double-blind, placebo-controlled, phase III trial

Identification of novel serum protein biomarkers in the context of 3P medicine for intravenous leiomyomatosis: a data-independent acquisition mass spectrometry-based proteomics study.

765P SABRINA study: A phase II study of senaparib monotherapy for patients (pts) with BRCA1/2 mutated recurrent platinum-sensitive ovarian cancer (PSOC)

Supplementary Figure S1 from C-X-C Motif Chemokine Ligand 9 Correlates with Favorable Prognosis in Triple-Negative Breast Cancer by Promoting Immune Cell Infiltration

Supplementary Table S2 from C-X-C Motif Chemokine Ligand 9 Correlates with Favorable Prognosis in Triple-Negative Breast Cancer by Promoting Immune Cell Infiltration

Supplementary Table S6 from C-X-C Motif Chemokine Ligand 9 Correlates with Favorable Prognosis in Triple-Negative Breast Cancer by Promoting Immune Cell Infiltration

Supplementary Figure S2 from C-X-C Motif Chemokine Ligand 9 Correlates with Favorable Prognosis in Triple-Negative Breast Cancer by Promoting Immune Cell Infiltration

SNM: Roll-to-Roll Manufacturing of High Quality Bucky-tape with Aligned and Crosslinked Carbon Nanotubes Through In-line Sensing and Control